13D/13G Filings - SOLENO THERAPEUTICS INC (SLNO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-11-09
4:46 pm
Purchase
2020-10-30 13G Soleno Therapeutics, Inc.
SLNO
SUVRETTA CAPITAL MANAGEMENT LLC 383,880
7.200%
383,880increase
(New Position)
Filing
History
2020-07-16
7:10 pm
Purchase
2019-03-21 13D Soleno Therapeutics, Inc.
SLNO
Jack W. Schuler Living Trust 842,998
15.650%
454,546increase
(+117.01%)
Filing
History
2020-07-06
4:00 pm
Purchase
2020-06-26 13D Soleno Therapeutics, Inc.
SLNO
Abingworth LLP 702,960
13.200%
376,055increase
(+115.04%)
Filing
History
Goto Prev, 0, 1, 2, 3